Nisa Investment Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-189,807
Closed -$6.3M 2815
2022
Q4
$6.3M Buy
189,807
+158,000
+497% +$5.09M 0.05% 365
2022
Q3
$1M Buy
31,807
+27
+0.1% +$874 0.01% 806
2022
Q2
$967K Hold
31,780
0.01% 837
2022
Q1
$825K Hold
31,780
0.01% 933
2021
Q4
$663K Buy
31,780
+8,990
+39% +$172K 0.01% 942
2021
Q3
$438 Buy
22,790
+5,000
+28% +$99.7K ﹤0.01% 1153
2021
Q2
$395 Sell
17,790
-3,300
-16% -$70K ﹤0.01% 1197
2021
Q1
$554 Sell
21,090
-2,600
-11% -$61.8K ﹤0.01% 1144
2020
Q4
$443K Buy
23,690
+2,350
+11% +$43.9K ﹤0.01% 1200
2020
Q3
$362K Sell
21,340
-90
-0.4% -$1.75K ﹤0.01% 1137
2020
Q2
$499K Buy
21,430
+3,355
+19% +$48.6K ﹤0.01% 1019
2020
Q1
$152K Sell
18,075
-31,700
-64% -$267K ﹤0.01% 1264
2019
Q4
$486K Buy
49,775
+7,185
+17% +$67.5K ﹤0.01% 1105
2019
Q3
$404K Buy
42,590
+17,370
+69% +$183K ﹤0.01% 1151
2019
Q2
$300K Sell
25,220
-900
-3% -$10.8K ﹤0.01% 1225
2019
Q1
$460K Buy
26,120
+1,100
+4% +$18.3K ﹤0.01% 1087
2018
Q4
$434K Buy
25,020
+200
+0.8% +$3.41K ﹤0.01% 1037
2018
Q3
$370K Buy
24,820
+1,300
+6% +$20.2K ﹤0.01% 1178
2018
Q2
$374K Buy
23,520
+9,000
+62% +$134K ﹤0.01% 1128
2018
Q1
$204K Buy
14,520
+1,500
+12% +$22.2K ﹤0.01% 1234
2017
Q4
$182K Buy
13,020
+6,200
+91% +$90.8K ﹤0.01% 1291
2017
Q3
$98K Sell
6,820
-6,500
-49% -$92.9K ﹤0.01% 1376
2017
Q2
$193K Sell
13,320
-820
-6% -$11.8K ﹤0.01% 1240
2017
Q1
$195K Sell
14,140
-3,460
-20% -$48.4K ﹤0.01% 1257
2016
Q4
$312K Buy
17,600
+1,300
+8% +$22.8K ﹤0.01% 1152
2016
Q3
$314K Buy
16,300
+7,800
+92% +$153K ﹤0.01% 1133
2016
Q2
$166K Sell
8,500
-100
-1% -$1.96K ﹤0.01% 1258
2016
Q1
$177K Buy
+8,600
New +$169K ﹤0.01% 1243

Other funds holding VIVO

Nisa Investment Advisors's VIVO Position: Q1 2023 in Review

Nisa Investment Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 189,807 shares — an estimated $6.3M sold.

Nisa Investment Advisors first reported a position in VIVO in Q1 2016 and held it in 28 quarters. The position peaked at $6.3M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Nisa Investment Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 189,807 Meridian Bioscience Inc shares in Q1 2023, an estimated $6.3M.
  • Nisa Investment Advisors first reported a position in Meridian Bioscience Inc in Q1 2016 and held it in 28 quarters.
  • Nisa Investment Advisors's Meridian Bioscience Inc position peaked at $6.3M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Nisa Investment Advisors's 13F filing for Q1 2023, filed 2 May 2023.